Skip to main content

Test Price

2,800 AED

โœ… Home Collection Available

GFER Gene-Related Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay โ€“ Genetic Test in UAE

Executive Summary โ€” Diagnostic Confidence

  • โœ“Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
  • โœ“Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
  • โœ“Clinical Guidance: Telephonic Post-Test Clinical Guidance for comprehensive result interpretation by certified genetic counselors.
  • โœ“Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
  • โœ“Molecular Confirmation: Definitive diagnosis of GFER-related mitochondrial myopathy with congenital cataract, sensorineural hearing loss, and developmental delay via full-gene NGS analysis.

This comprehensive next-generation sequencing assay analyzes the entire coding region of the GFER gene to detect pathogenic variants causing a rare syndromic mitochondrial disorder. The test provides definitive molecular confirmation, guides targeted surveillance and management, and empowers informed family planning through accurate recurrence risk assessment.

Test Overview & Methodology

The GFER Gene Genetic Test is a comprehensive next-generation sequencing assay that analyzes the entire coding region of the GFER (Growth Factor, Augmenter of Liver Regeneration) gene to detect pathogenic variants causing mitochondrial progressive myopathy with congenital cataract, sensorineural hearing loss, and global developmental delay. This test provides definitive molecular confirmation for clinical diagnosis, guides targeted management, and enables informed family planning through accurate recurrence risk assessment.

FeatureOur GFER NGS TestClosest Alternative (Single-Gene Sanger)
PrecisionFull gene coverage with >99.9% analytical sensitivity; detects SNVs, indels, and copy number variantsSequential exon-by-exon analysis; may miss deep intronic variants and large deletions
MethodologyNGS (Next-Generation Sequencing) with confirmatory Sanger validationSanger Sequencing only; limited throughput
Turnaround Speed3 to 4 Weeks with comprehensive clinical report6 to 8 Weeks for full gene coverage

Physician Insight & Safety Protocols

Clinical Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403):

"The GFER gene encodes a critical mitochondrial disulfide relay protein, and pathogenic variants produce a distinct syndromic phenotype that requires careful clinical correlation. I emphasize that this genetic test result must always be interpreted within the full clinical contextโ€”alongside neurological examination, audiological assessment, ophthalmological evaluation, and detailed developmental historyโ€”to ensure accurate diagnosis. Families should understand that a positive result confirms the molecular etiology and empowers targeted surveillance, while a negative or variant-of-uncertain-significance result may necessitate broader genomic investigation or periodic reanalysis."

โš  Advisory โ€” Medication Continuity & Clinical Safety

Do not discontinue any prescribed medication or supplement without consulting your treating physician. Genetic testing does not replace ongoing clinical management. Altering medication regimens without medical supervision may lead to serious adverse events including metabolic decompensation or seizure exacerbation in mitochondrial disorders. Always maintain open communication with your specialist throughout the diagnostic process.

Patient FAQ & Clinical Guidance

1. What is the GFER gene test, and why is it essential for diagnosing mitochondrial progressive myopathy with congenital cataract and hearing loss?

The GFER gene NGS test comprehensively sequences the entire GFER coding region to identify pathogenic mutations responsible for this rare autosomal recessive mitochondrial disorder, enabling definitive molecular diagnosis, precise recurrence risk counseling, and informed clinical management planning for affected individuals and their families.

2. How is the sample collected for this genetic test, and what turnaround time should I expect?

A certified DHA-licensed phlebotomist performs a simple venous blood draw or FTA card finger-prick during a scheduled home visit, with specimens transported under ISO-certified cold-chain conditions to our accredited laboratory. Your comprehensive clinical report will be delivered within 3 to 4 weeks from sample receipt.

3. Is the GFER gene NGS test covered by medical insurance in the UAE, and how do I verify my coverage?

Many UAE-based insurance providers cover medically necessary genetic testing when supported by a specialist referral from a neurologist or pediatrician. Our dedicated billing team offers direct insurance verification via WhatsApp at +971 54 548 8731, confirming your policy benefits before sample collection.

4. What clinical documentation is required before undergoing this genetic test?

Your referring physician must provide comprehensive neurological, ophthalmological, and audiological history including age of symptom onset, developmental milestones, and any prior metabolic or mitochondrial workup. A mandatory pre-test genetic counseling session is required to construct a detailed pedigree chart documenting all family members affected by GFER-related conditions. Written informed consent must be provided by the patient or legal guardian for minors in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.

UAE Regulatory & Data Privacy Adherence

  • โœ“ Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ€” Genomic Data Privacy & Consent
  • โœ“ Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ€” Health Data Security
  • โœ“ Federal Decree-Law No. 4 of 2016 on Medical Liability โ€” Clinical Testing Safety & Patient Consent
  • โœ“ ISO 9001:2015 Certified โ€” Cert: INT/EGQ/2509DA/3139
  • โœ“ DHA-MOHAP Standard Nomenclature Compliance
  • โœ“ DHA Facility License No. 1143 โ€” Dubai Healthcare City Regulated

Clinical & Logistical Metadata

Test NameGFER Gene-Related Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay โ€“ Genetic Test (NGS Full Gene Sequencing)
Price (AED)2,800 AED
Turnaround Time3 to 4 Weeks
Sample Type / MatrixWhole Blood (EDTA tube), Extracted DNA (minimum 1 ยตg at โ‰ฅ50 ng/ยตL), or One Drop of Blood on FTA Card โ€” VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM โ€“ 11 PM
Methodology UsedNext-Generation Sequencing (NGS) with confirmatory Sanger validation; bioinformatic analysis per ACMG/AMP variant classification guidelines
ICD-10-CM CodeG71.8, H90.5, Q12.0, Z15.89
LOINC Code86204-6
DHA Facility License & Laboratory AddressLicense No. 1143 โ€” Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians